Surveillance for Cancers Associated with Tobacco Use — United States, 2010–2014

Abstract

Problem/ConditionTobacco use is the leading preventable cause of cancer, contributing to at least 12 types of cancer, including acute myeloid leukemia (AML) and cancers of the oral cavity and pharynx; esophagus; stomach; colon and rectum; liver; pancreas; larynx; lung, bronchus, and trachea; kidney and renal pelvis; urinary bladder; and cervix. This report provides a comprehensive assessment of recent tobacco-associated cancer incidence for each cancer type by sex, age, race/ethnicity, metropolitan county classification, tumor characteristics, U.S. census region, and state. These data are important for initiation, monitoring, and evaluation of tobacco prevention and control measures.Period Covered2010–2014.Description of SystemCancer incidence data from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results program were used to calculate average annual age-adjusted incidence rates for 2010–2014 and trends in annual age-adjusted incidence rates for 2010–2014. These cancer incidence data cover approximately 99% of the U.S. population. This report provides age-adjusted cancer incidence rates for each of the 12 cancer types known to be causally associated with tobacco use, including liver and colorectal cancer, which were deemed to be causally associated with tobacco use by the U.S. Surgeon General in 2014. Findings are reported by demographic and geographic characteristics, percentage distributions for tumor characteristics, and trends in cancer incidence by sex.ResultsDuring 2010–2014, approximately 3.3 million new tobacco-associated cancer cases were reported in the United States, approximately 667,000 per year. Age-adjusted incidence rates ranged from 4.2 AML cases per 100,000 persons to 61.3 lung cancer cases per 100,000 persons. By cancer type, incidence rates were higher among men than women (excluding cervical cancer), higher among non-Hispanics than Hispanics (for all cancers except stomach, liver, kidney, and cervical), higher among persons in nonmetropolitan counties than those in metropolitan counties (for all cancers except stomach, liver, pancreatic, and AML), and lower in the West than in other U.S. census regions (all except stomach, liver, bladder, and AML). Compared with other racial/ethnic groups, certain cancer rates were highest among whites (oral cavity and pharyngeal, esophageal, bladder, and AML), blacks (colon and rectal, pancreatic, laryngeal, lung and bronchial, cervical, and kidney), and Asians/Pacific Islanders (stomach and liver). During 2010–2014, the rate of all tobacco-associated cancers combined decreased 1.2% per year, influenced largely by decreases in cancers of the larynx (3.0%), lung (2.2%), colon and rectum (2.1%), and bladder (1.3%).InterpretationAlthough tobacco-associated cancer incidence decreased overall during 2010–2014, the incidence remains high in several states and subgroups, including among men, whites, blacks, non-Hispanics, and persons in nonmetropolitan counties. These disproportionately high rat...

Cancer rates not explained by smoking: a county-level analysis

“…We chose to study 12 cancer types which are considered to be caused by smoking according to the U.S. Centers for Disease Control and Prevention [8]. These can be divided into two groupsthree airways cancers and nine other smoking-related cancers.…”

COVID-19 in the Cancer Patient

“…The majority are also diagnosed with chronic obstructive pulmonary disease. 45 One prospective cohort study determined the most frequent type of cancer among COVID-19 patients was lung cancer (28% of COVID-19 cases). 6 Recent data demonstrated a significantly higher angiotensin-converting enzyme 2 (ACE2) gene expression in former smoker's lung compared to nonsmoker's lung.…”

A Qualitative Study of Smoking‐Related Causal Attributions and Risk Perceptions in Cervical Cancer Survivors

“…Despite its status as a smoking‐related cancer , cervical cancer is a disease site that is often ignored in psychosocial/behavioral studies of smoking after cancer diagnosis. The current study's focus on this group is therefore remarkable, but the study is not without limitations.…”

“…Of all the health behaviors and related factors associated with cervical cancer risk , probably none has as significant an effect on cervical cancer prognosis as cigarette smoking. Smoking is an established cause of cervical cancer and a major detriment to the health and wellbeing of cancer survivors, as it increases risk for all‐cause mortality, cancer‐specific mortality, recurrence, second primary, and poorer response to, and more complications after, cancer treatment .…”

“…In the United States (US), approximately 250,000 cervical cancer survivors (CCS) are alive today, with 13,170 new cases projected for 2019 . Despite recent stability in incidence and modest declines in mortality , cervical cancer remains a key public health target because it is highly preventable and behavioral factors after diagnosis can have a significant bearing on clinical outcomes and quality of life. Of all the health behaviors and related factors associated with cervical cancer risk , probably none has as significant an effect on cervical cancer prognosis as cigarette smoking.…”